N-[5-[5-chloro-2-methoxy-6-methyl-3-[2-(7H-purin-6-ylamino)ethyl]phenyl]-2-pyridinyl]acetamide
C22H22ClN7O2 — CID 146590543
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[5-chloro-2-methoxy-6-methyl-3-[2-(7H-purin-6-ylamino)ethyl]phenyl]-2-pyridinyl]acetamide
N-[5-[5-chloro-2-methoxy-6-methyl-3-[2-(7H-purin-6-ylamino)ethyl]phenyl]-2-pyridinyl]acetamide (PubChem CID 146590543) has the molecular formula C22H22ClN7O2 and a molecular weight of 451.92 g/mol. Its IUPAC name is N-[5-[5-chloro-2-methoxy-6-methyl-3-[2-(7H-purin-6-ylamino)ethyl]phenyl]-2-pyridinyl]acetamide.
Molecular Properties
| Compound Name | N-[5-[5-chloro-2-methoxy-6-methyl-3-[2-(7H-purin-6-ylamino)ethyl]phenyl]-2-pyridinyl]acetamide |
|---|---|
| PubChem CID | 146590543 |
| Molecular Formula | C22H22ClN7O2 |
| Molecular Weight | 451.92 g/mol |
| Exact Mass | 451.15 |
| IUPAC Name | N-[5-[5-chloro-2-methoxy-6-methyl-3-[2-(7H-purin-6-ylamino)ethyl]phenyl]-2-pyridinyl]acetamide |
| SMILES | COc1c(CCNc2ncnc3nc[nH]c23)cc(Cl)c(C)c1-c1ccc(NC(C)=O)nc1 |
| InChI | InChI=1S/C22H22ClN7O2/c1-12-16(23)8-14(6-7-24-21-19-22(27-10-26-19)29-11-28-21)20(32-3)18(12)15-4-5-17(25-9-15)30-13(2)31/h4-5,8-11H,6-7H2,1-3H3,(H,25,30,31)(H2,24,26,27,28,29) |
| InChIKey | ONBLCKVJWGHCTL-UHFFFAOYSA-N |
| XLogP | 4.00 |
| TPSA | 117.71 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 451.92 |
| LogP ≤ 5 | 4.00 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146590543 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.